198064-38-9

Upstream product

• 198063-87-5 methyl 3-[2-chloro-4-(4-chlorophenyl)-5-oxazolyl]propionate 
• 198064-80-1 methyl 5-(4-chlorophenyl)-5-oxo-4-(phenyoxycarbonyloxy)pentanoate 
• 198063-88-6 3-[2-chloro-4-(4-chlorophenyl)-5-oxazolyl]propionic acid 
• 198064-81-2 methyl 3-[4-(4-chlorophenyl)-2-oxo-2,3-dihydro-5-oxazolyl]propionate 
• 89150-43-6 methyl 4-bromo-5-(4-chlorophenyl)-5-oxopentanoate 
• 198064-79-8 methyl 5-(4-chlorophenyl)-4-hydroxy-5-oxopentanoate 
• 108-90-7 chlorobenzene 
• 71354-29-5 methyl 5-(4-chlorophenyl)-5-oxopentanoate 
• 1501-26-4 methyl 4-(chlorocarbonyl)butyrate 
• 75-03-6 ethyl iodide 
• 198064-11-8 3-[4-(4-chlorophenyl)-2-(2-methyl-1H-imidazol-1-yl)-5-oxazolyl]propionic acid 

Relevant academic research and scientific papers

Synthesis and biological activity of novel 5-(omega-aryloxyalkyl)oxazole derivatives as brain-derived neurotrophic factor inducers.

A novel series of 5-(omega-aryloxyalkyl)oxazole derivatives was prepared and their effects on brain-derived neurotrophic factor (BDNF) production were evaluated in human neuroblastoma (SK-N-SH) cells. Syntheses were performed by construction of an oxazole

Oxazole derivatives, their production and use

A novel compound of the formula: wherein R1 is a halogen atom, an optionally substituted heterocyclic, hydroxy, thiol or amino group; A is an optionally substituted acyl group, an optionally substituted heterocyclic group, an optionally substituted hydroxy group, or an optionally esterified or amidated carboxy group; B is an optionally substituted aromatic group; Y is a divalent aliphatic hydrocarbon group, or a salt thereof, which have an excellent insulin secertion-promoting and blood sugar-depressing effect, and useful in agents for diabetes.